Cofetuzumab (PF-06523435) is a monoclonal antibody targeting protein tyrosine kinase 7 (PTK7). It can be used to synthesize the ADC compound cofetuzumab pelidotin.
Purity:
96.42%
CAS Number:
[1869928-62-0]
Target:
Tyrosine Kinases|||c-RET
T82696
* VAT and and shipping costs not included. Errors and price changes excepted